C1QTNF9 and diabetes mellitus: CTRP9 has been shown to improve endothelial function and protect the macro- and microvasculature in diabetes via mechanisms that appear to be independent of its hypoglycemic actions (Cheng et al., 2016; Li et al., 2019; Hu et al., 2020).